RT @PopovianPharmD: Garbage in, garbage out, drug…

RT @PopovianPharmD: Garbage in, garbage out, drug list prices, useless when debating drug costs, need net spending on drugs wsj.com/articles/drugm… via @WSJ

RT @emmarcourt: Ye gods. Mylan’s EpiPen Profit 60%…

RT @emmarcourt: Ye gods. Mylan’s EpiPen Profit 60% Higher Than Told to Congress on.wsj.com/2dmdB5j via @WSJ

RT @LauraLandroWSJ: Doctors, hospitals create ever…

RT @LauraLandroWSJ: Doctors, hospitals create ever more complex algorithms to forecast patients’ medical future @melaevans t on.wsj.com/2cOvSTp via @WSJ

RT @ScottGottliebMD: My op ed in tomorrow’s @WSJ e…

RT @ScottGottliebMD: My op ed in tomorrow’s @WSJ edit page on path to single payer: Clinton’s stealthy single-payer gambit wsj.com/articles/clint… @WSJopinion

RT @annawmathews: Discussion of Aetna’s ACA pullba…

RT @annawmathews: Discussion of Aetna’s ACA pullback is part of broader debate over cause/cure for insurers’ exchange losses on.wsj.com/2bxY6Ts via @WSJ

RT @annawmathews: The economics of what’s not work…

RT @annawmathews: The economics of what’s not working in the ACA: a fascinating column from Greg Ip on.wsj.com/2byDL0s via @WSJ @greg_ip

RT @accountablecare: More nonprofit hospitals are…

RT @accountablecare: More nonprofit hospitals are becoming more transparent to attract investors on.wsj.com/1TnvbSB via @WSJ

RT @HCFO: Payments to insurers that offer #Medicar…

RT @HCFO: Payments to insurers that offer #MedicareAdvantage plans to rise slightly in 2017, but less than expected via @WSJ ht.ly/10jCYS

RT @mjkeegan1127: Price freeze complicates Oregon…

RT @mjkeegan1127: Price freeze complicates Oregon insurance extension; insurers have until today to decide on.wsj.com/18rvfJP via @WSJ

RT @charlesornstein: Caution: this could be bad if…

RT @charlesornstein: Caution: this could be bad if it holds. Young Avoid New Health Coverage, via @WSJ on.wsj.com/HDhSwd